The NYSE listing application is the primary catalyst — monitor for SEC/NYSE approval and the Stock Exchange Permissibility Date (rescheduling of marijuana). The deconsolidation removes retail segment volatility from reported financials. If listing succeeds, expect multiple expansion and institutional inflow. If delayed, stock may trade on OTC at discount.
Price Chart
Executive Summary
Glass House Brands deconsolidated its dual-use cannabis retail business (Glass House Retail) by selling a 10% voting stake to a third-party investor for $2.5M and retaining 90% non-voting economic interest, in order to apply for NYSE listing. The pro forma impact removes retail revenue (Q1 2026: from $40.5M to $28.6M; FY2025: from $182M to $133.7M) and recognizes an $11.4M loss on deconsolidation. The NYSE listing application is a significant catalyst but contingent on regulatory permissibility.
Key Facts
- Deconsolidation of Glass House Retail closed June 12, 2026.
- NSJB Investments paid $2.5M for 100 Class A voting units (10% economic stake).
- Glass House applied to list subordinate voting shares on NYSE on June 17, 2026.
- Pro forma Q1 2026 revenue reduced from $40.5M to $28.6M; FY2025 revenue from $182M to $133.7M.
- Pro forma FY2025 net loss increased from $29.7M to $40.6M due to $11.4M deconsolidation loss.
- Retained 900 exchangeable units (90% economic interest) non-voting until NYSE Permissibility Date.
- Distributions to Class A holders capped at $25,000/month during Interim Period.
- Current stock at OTC, with analyst consensus 82% bullish (9 buys, 2 holds).
Financial Impact
Annual revenue reduced by ~$48M (26%), net loss increased by ~$11M from deconsolidation loss. No change to cash flow from operations in retained business.
Risk Factors
- NYSE listing may be denied if regulatory permissibility condition not met.
- Loss of control over Glass House Retail during Interim Period could impact value of exchangeable units.
- Pro forma financials show larger net loss and lower revenue scale, which may temporarily unsettle investors.
- Regulatory risk: cannabis federal rescheduling may not occur as anticipated.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-074968 |
| Document: tm2617929d1_ex99-2.htm | 0001104659-26-074968 |
| Document: tm2617929d1_ex99-4.htm | 0001104659-26-074968 |
| Document: tm2617929d1_ex99-3.htm | 0001104659-26-074968 |
| Document: tm2617929d1_ex99-1.htm | 0001104659-26-074968 |
| Document: tm2617929d1_6k.htm | 0001104659-26-074968 |
| Document: tm2617929d1_ex99-6.htm | 0001104659-26-074968 |
| Document: 0001104659-26-074968-index-headers.html | 0001104659-26-074968 |
| Document: 0001104659-26-074968-index.html | 0001104659-26-074968 |
| Document: 0001104659-26-074968.txt | 0001104659-26-074968 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access